All ESMO Abstracts 2020

Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now

About
Consulting
Capabilities
Report Store
Insights
Login
Contact
Cart
0

Home
ESMO Conference 2020
All

Filters:
Targets/Technology

Immune Checkpoint Inhibitors

Classes showing abundant growth (PARP inhibitors, CDK4/6 inhibitors)

Others

Cell therapies (CAR-T/TCR/TCR2)

Promising new classes (viz.AKT inhibitors; BiTE)

multiTKI

Bispecific Antibodies

BCMA-ADC

Promising next gen Immunotherapies (LAG-3/ICOS/TIM-3)

+ SHOW MORE
Indications

Others

Breast Cancer( HER2-ve; HER2+ve, TNBC)

Melanoma

Lung Cancer (NSCLC; SCLC)

Renal Cell Carcinoma (RCC)

Urothelial Carcinoma

Head and Neck Cancer

Colorectal Cancer

Glioblstoma; High Grade Glioma

Merkel cell carcinoma

Diffused Large B-Cell Lymphoma (DLBCL)

Prostate Cancer (HSPC, CRPC)

Ovarian Cancer

Cutaneous squamous cell carcinoma (SCC)

Cervical Cancer

Gastrointestinal Cancer

Gastroesophageal adenocarcinoma

Adenoid Cystic Carcinoma

Pancreatic Cancer

Thyroid Cancer

+ SHOW MORE

-- End of the Page --

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Subscribe for latest updates

Useful Links

Home
About Us
PharmDelve
Careers
Privacy Policy

Blog
Events
Newsletter
Report Store
Competitive Intelligence

Sitemap
Case Study
Press Release
Market Research
Business Consulting

We accept :

Paypal

Visa

Discover

Mastercard

USA:

+1(919)321-6187

India:

+91-11-45689769,

info@delveinsight.com

USA:

304 S. Jones Blvd #2432, Las Vegas NV 89107

India:

Sector-7, Dwarka, New Delhi-110077, India

DelveInsight Business Research LLP © 2021 Terms & Conditions

We use cookies to personalize content. Know more about our Privacy Policy.

Accept